Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.76, $0.25 better than the analyst estimate of $0.51. Revenue for the quarter came in at $277.6 million versus the consensus estimate of $268.04 million.

"Q3 results were strong, and we continued to build momentum with our new initiatives," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We opened our first Dolby Cinema locations in China, grew the number of Dolby Vision televisions in market, and added a new Dolby Voice partner."

GUIDANCE:

Dolby Laboratories sees Q4 2016 EPS of $0.31-$0.37, versus the consensus of $0.29. Dolby Laboratories sees Q4 2016 revenue of $220-230 million, versus the consensus of $239.88 million.

Dolby Laboratories sees FY2016 revenue of $1.015-1.025 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.